{"schema_version":"secwatch.filing_event.v1","accession":"0001014739-24-000007","form_type":"8-K","ticker":"OPCH","cik":"0001014739","company_name":"Option Care Health, Inc.","filed_at":"2024-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.103106+00:00","generated_at":"2026-06-05T18:03:54.811025+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Option Care Health Q4 revenue up 9.5% to $1.12B; EPS $0.32; FY guides $4.6-4.8B","bullets":["Q4 net revenue $1,124.4M (+9.5% YoY); net income $57.2M ($0.32 EPS) vs $47.5M ($0.26 EPS).","Full-year 2023 revenue $4,302.3M (+9.1%); net income $267.1M ($1.48 diluted EPS) vs $150.6M ($0.83 EPS).","FY 2024 guidance: revenue $4.6B-$4.8B; Adjusted EBITDA $425M-$450M; cash from ops ≥$300M.","Board authorized $250M additional share repurchase after completing prior $250M authorization.","Adjusted EBITDA Q4 $111.6M (+18.4% YoY); FY $425.2M (+24% YoY); cash flow from ops FY $371.3M (+38.8%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001014739-24-000007","json":"https://secwatch.observer/filing/0001014739-24-000007.json","markdown":"https://secwatch.observer/filing/0001014739-24-000007.md","text":"https://secwatch.observer/filing/0001014739-24-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/0001014739-24-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/bios-20240222.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T18:03:54.811025+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"06702eb9517adb20aecd2b6480b6608141afc7de","claim":"Option Care Health, Inc. reported fourth quarter and full year ended December 31, 2023 results: revenue Net revenue of $1,124.4 million, net income Net income of $57.2 million, EPS $0.32 earnings per share.","evidence_excerpt":"site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights • Net revenue of $1,124.4 million, up 9.5% compared to $1,027.2 million in the fourth quarter of 2022 • Gross profit of $247.1 million, or 22.0% of revenue, up 6.9% compared to $231.1 million, or 22.5% of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/0001014739-24-000007-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year ended December 31, 2023"},{"label":"Revenue","value":"Net revenue of $1,124.4 million"},{"label":"Net income","value":"Net income of $57.2 million"},{"label":"EPS","value":"$0.32 earnings per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"c7231d16eec7cf6c91c2facd99268913cce52d54","claim":"Option Care Health, Inc. reported full year 2024 results: revenue Net revenue of $4.6 billion to $4.8 billion. Guidance reaffirmed.","evidence_excerpt":"For the full year 2024, Option Care Health expects to deliver the following financial results: • Net revenue of $4.6 billion to $4.8 billion • Adjusted EBITDA of $425 million to $450 million • Cash flow from operations of at least $300 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/0001014739-24-000007-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2024"},{"label":"Revenue","value":"Net revenue of $4.6 billion to $4.8 billion"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"f222fce67c530ac19c61dc21ae25b38a9c6ea5e1","claim":"Option Care Health, Inc. reported full year ended December 31, 2023 results: revenue Net revenue of $4,302.3 million, net income Net income of $267.1 million, EPS $1.48 diluted earnings per share.","evidence_excerpt":"Full Year 2023 Financial Highlights • Net revenue of $4,302.3 million, up 9.1% compared to $3,944.7 million in full year 2022 • Gross profit of $981.2 million, or 22.8% of revenue, up 13.2% compared to $866.9 million, or 22.0% of revenue, in full year 2022 • Net income of $267.1 million, or $1.48 diluted earnings per share, compared to net income of $150.6 million, or $0.83 earnings per share, in full year 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/0001014739-24-000007-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year ended December 31, 2023"},{"label":"Revenue","value":"Net revenue of $4,302.3 million"},{"label":"Net income","value":"Net income of $267.1 million"},{"label":"EPS","value":"$1.48 diluted earnings per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}